Annals of Surgery, ISSN 0003-4932, 02/2014, Volume 259, Issue 2, pp. 315 - 322
OBJECTIVE:The outcome of pelvic exenteration was compared in patients with locally advanced primary (LAP) cancer and recurrent rectal cancer (RRC)....
recurrent rectal cancer | locally advanced rectal cancer | exenteration | SURGERY | MESORECTAL EXCISION | RADICAL RESECTION | CHEMORADIATION | Humans | Middle Aged | Carcinoma - mortality | Male | Chemoradiotherapy, Adjuvant | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Neoplasm Recurrence, Local - pathology | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Rectal Neoplasms - pathology | Carcinoma - pathology | Rectal Neoplasms - surgery | Carcinoma - surgery | Neoplasm Recurrence, Local - therapy | Treatment Outcome | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Pelvic Exenteration | Survival Analysis | Carcinoma - therapy | Aged | Neoplasm Staging
recurrent rectal cancer | locally advanced rectal cancer | exenteration | SURGERY | MESORECTAL EXCISION | RADICAL RESECTION | CHEMORADIATION | Humans | Middle Aged | Carcinoma - mortality | Male | Chemoradiotherapy, Adjuvant | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - surgery | Neoplasm Recurrence, Local - pathology | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Rectal Neoplasms - pathology | Carcinoma - pathology | Rectal Neoplasms - surgery | Carcinoma - surgery | Neoplasm Recurrence, Local - therapy | Treatment Outcome | Rectal Neoplasms - therapy | Rectal Neoplasms - mortality | Pelvic Exenteration | Survival Analysis | Carcinoma - therapy | Aged | Neoplasm Staging
Journal Article
Radiotherapy and Oncology, ISSN 0167-8140, 2008, Volume 87, Issue 3, pp. 449 - 474
Abstract The main evidences of epidemiology, diagnostic imaging, pathology, surgery, radiotherapy, chemotherapy and follow-up are reviewed to optimize the...
Hematology, Oncology and Palliative Medicine | Adjuvant chemotherapy | Randomized clinical trial | Local recurrence | Diagnostic | Early stage | Scenario of ongoing research | Epidemiology | Follow-up | Surgery | Endorectal ultrasound | Total mesorectal excision | Advanced stage | Intraoperative radiotherapy | Acute and late toxicity | Post-operative treatment | Concomitant radiochemotherapy | Educational | Radiotherapy | Pre-operative treatment | Radiotherapy technique | Computerized tomography | Quality of life | Pathology | Chemotherapy | Magnetic resonance imaging | Combined modality therapy | Rectal cancer treatment | Local excision | Intermediate stage | adjuvant chemotherapy | magnetic resonance imaging | pathology | COMBINED-MODALITY THERAPY | intraoperative radiotherapy | LOCALLY ADVANCED PRIMARY | CIRCUMFERENTIAL RESECTION MARGIN | scenario of ongoing research | concomitant radiochemotherapy | rectal cancer treatment | chemotherapy | COURSE PREOPERATIVE RADIOTHERAPY | total mesorectal excision | intermediate stage | epidemiology | follow-up | GROWTH-FACTOR RECEPTOR | INTRAOPERATIVE RADIATION-THERAPY | radiotherapy technique | FLUOROURACIL-BASED CHEMOTHERAPY | RANDOMIZED PHASE-III | endorectal ultrasound | local excision | combined modality therapy | local recurrence | diagnostic | computerized tomography | QUALITY-OF-LIFE | educational | acute and late toxicity | randomized clinical trial | advanced stage | post-operative treatment | ONCOLOGY | radiotherapy | pre-operative treatment | quality of life | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | surgery | early stage | Rectal Neoplasms - diagnosis | Humans | Risk Factors | Combined Modality Therapy | Rectal Neoplasms - pathology | Rectal Neoplasms - epidemiology | Rectal Neoplasms - therapy | Oncology, Experimental | Research | Cancer | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICINE | MEDICIN
Hematology, Oncology and Palliative Medicine | Adjuvant chemotherapy | Randomized clinical trial | Local recurrence | Diagnostic | Early stage | Scenario of ongoing research | Epidemiology | Follow-up | Surgery | Endorectal ultrasound | Total mesorectal excision | Advanced stage | Intraoperative radiotherapy | Acute and late toxicity | Post-operative treatment | Concomitant radiochemotherapy | Educational | Radiotherapy | Pre-operative treatment | Radiotherapy technique | Computerized tomography | Quality of life | Pathology | Chemotherapy | Magnetic resonance imaging | Combined modality therapy | Rectal cancer treatment | Local excision | Intermediate stage | adjuvant chemotherapy | magnetic resonance imaging | pathology | COMBINED-MODALITY THERAPY | intraoperative radiotherapy | LOCALLY ADVANCED PRIMARY | CIRCUMFERENTIAL RESECTION MARGIN | scenario of ongoing research | concomitant radiochemotherapy | rectal cancer treatment | chemotherapy | COURSE PREOPERATIVE RADIOTHERAPY | total mesorectal excision | intermediate stage | epidemiology | follow-up | GROWTH-FACTOR RECEPTOR | INTRAOPERATIVE RADIATION-THERAPY | radiotherapy technique | FLUOROURACIL-BASED CHEMOTHERAPY | RANDOMIZED PHASE-III | endorectal ultrasound | local excision | combined modality therapy | local recurrence | diagnostic | computerized tomography | QUALITY-OF-LIFE | educational | acute and late toxicity | randomized clinical trial | advanced stage | post-operative treatment | ONCOLOGY | radiotherapy | pre-operative treatment | quality of life | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | surgery | early stage | Rectal Neoplasms - diagnosis | Humans | Risk Factors | Combined Modality Therapy | Rectal Neoplasms - pathology | Rectal Neoplasms - epidemiology | Rectal Neoplasms - therapy | Oncology, Experimental | Research | Cancer | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICINE | MEDICIN
Journal Article
Diseases of the Colon & Rectum, ISSN 0012-3706, 04/2013, Volume 56, Issue 4, pp. 519 - 531
BACKGROUND:Pelvic exenteration is a potentially curative treatment for locally advanced primary or recurrent rectal cancer. OBJECTIVE:This systematic review...
Rectal cancer | Pelvic exenteration | SURGERY | LOCALLY ADVANCED PRIMARY | RECONSTRUCTION | SURGICAL-MANAGEMENT | SACRAL RESECTION | RADICAL SURGERY | EXTENDED RESECTION | RECURRENT | COLORECTAL-CANCER | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | Rectal Neoplasms - surgery | Humans | Pelvic Exenteration | Neoplasm Recurrence, Local | Rectal Neoplasms - pathology | Postoperative Complications | Rectal Neoplasms - mortality
Rectal cancer | Pelvic exenteration | SURGERY | LOCALLY ADVANCED PRIMARY | RECONSTRUCTION | SURGICAL-MANAGEMENT | SACRAL RESECTION | RADICAL SURGERY | EXTENDED RESECTION | RECURRENT | COLORECTAL-CANCER | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | CARCINOMA | Rectal Neoplasms - surgery | Humans | Pelvic Exenteration | Neoplasm Recurrence, Local | Rectal Neoplasms - pathology | Postoperative Complications | Rectal Neoplasms - mortality
Journal Article
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 09/2018, Volume 48, Issue 3, pp. 605 - 614
Background Locally advanced rectal cancer (LARC) patient stratification by clinicoradiologic factors may yield variable results. Therefore, more efficient...
biomarker | prognosis | locally advanced rectal cancer | radiomic signature | disease‐free survival | disease-free survival | EXTRAMURAL VENOUS INVASION | LEUCOVORIN | STAGE | CHEMORADIATION | PREOPERATIVE CHEMORADIOTHERAPY | OXALIPLATIN | DISEASE-FREE SURVIVAL | RADIOTHERAPY | FLUOROURACIL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Medicine, Experimental | Medical research | Analysis | Colorectal cancer | Model testing | Segmentation | Image processing | Population studies | Multivariate analysis | Risk factors | Rank tests | Training | Confidence intervals | Time dependence | Regression models | Mathematical models | Statistical analysis | Risk groups | Lava | Gastrointestinal tract | Shrinkage | Regression analysis | Statistical tests | Risk analysis | Patients | Survival | Field strength | Itk protein | Image segmentation | Population (statistical) | Magnetic resonance imaging | Gastrointestinal system | Rectum | Biomarkers | Cancer
biomarker | prognosis | locally advanced rectal cancer | radiomic signature | disease‐free survival | disease-free survival | EXTRAMURAL VENOUS INVASION | LEUCOVORIN | STAGE | CHEMORADIATION | PREOPERATIVE CHEMORADIOTHERAPY | OXALIPLATIN | DISEASE-FREE SURVIVAL | RADIOTHERAPY | FLUOROURACIL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | CHEMOTHERAPY | Medicine, Experimental | Medical research | Analysis | Colorectal cancer | Model testing | Segmentation | Image processing | Population studies | Multivariate analysis | Risk factors | Rank tests | Training | Confidence intervals | Time dependence | Regression models | Mathematical models | Statistical analysis | Risk groups | Lava | Gastrointestinal tract | Shrinkage | Regression analysis | Statistical tests | Risk analysis | Patients | Survival | Field strength | Itk protein | Image segmentation | Population (statistical) | Magnetic resonance imaging | Gastrointestinal system | Rectum | Biomarkers | Cancer
Journal Article
Cancer / Radiothérapie, ISSN 1278-3218, 09/2018, Volume 22, Issue 5, pp. 459 - 465
While outcomes for patients with locally advanced disease have improved considerably with combined modality therapy, there is now an emphasis on developing...
Induction chemotherapy | Locally advanced rectal cancer | Chimiothérapie d’induction | Chemoradiation | Chimioradiothérapie | Thérapie néoadjuvante totale | Cancer rectal localement évolué | Total neoadjuvant therapy | ADJUVANT CHEMOTHERAPY | CHEMORADIATION THERAPY | POSTOPERATIVE CHEMORADIOTHERAPY | FOLLOW-UP | TOTAL MESORECTAL EXCISION | PATHOLOGICAL COMPLETE RESPONSE | RADIATION-THERAPY | PHASE-III TRIAL | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | NONOPERATIVE TREATMENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Digestive System Surgical Procedures | Humans | Quality of Life | Neoadjuvant Therapy | Clinical Trials as Topic | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Rectal Neoplasms - therapy | Chemoradiotherapy
Induction chemotherapy | Locally advanced rectal cancer | Chimiothérapie d’induction | Chemoradiation | Chimioradiothérapie | Thérapie néoadjuvante totale | Cancer rectal localement évolué | Total neoadjuvant therapy | ADJUVANT CHEMOTHERAPY | CHEMORADIATION THERAPY | POSTOPERATIVE CHEMORADIOTHERAPY | FOLLOW-UP | TOTAL MESORECTAL EXCISION | PATHOLOGICAL COMPLETE RESPONSE | RADIATION-THERAPY | PHASE-III TRIAL | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | NONOPERATIVE TREATMENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Digestive System Surgical Procedures | Humans | Quality of Life | Neoadjuvant Therapy | Clinical Trials as Topic | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Rectal Neoplasms - therapy | Chemoradiotherapy
Journal Article
Surgical Endoscopy, ISSN 0930-2794, 8/2017, Volume 31, Issue 8, pp. 3106 - 3121
The use of laparoscopy for advanced-stage rectal cancer remains controversial. This study aimed to compare the operative and oncologic outcomes of laparoscopic...
Locally advanced rectal cancer | Rectal cancer | Gynecology | Propensity score matching | Laparoscopy | Open surgery | Medicine & Public Health | Surgery | Hepatology | Gastroenterology | Radiochemotherapy | Abdominal Surgery | Proctology | SURGERY | RANDOMIZED CLINICAL-TRIAL | PATHOLOGICAL OUTCOMES | TOTAL MESORECTAL EXCISION | CIRCUMFERENTIAL MARGIN | LOCAL RECURRENCE | LOW ANTERIOR RESECTION | COLORECTAL-CANCER | PREOPERATIVE RADIOTHERAPY | NEOADJUVANT CHEMORADIOTHERAPY | ASSISTED RESECTION | Length of Stay | Adenocarcinoma - pathology | Rectal Neoplasms - surgery | Humans | Middle Aged | Proportional Hazards Models | Male | Survival Rate | Treatment Outcome | Propensity Score | Aged, 80 and over | Adult | Female | Aged | Rectal Neoplasms - pathology | Rectum - surgery | Laparotomy | Neoplasm Staging | Elective Surgical Procedures | Adenocarcinoma - surgery | Digestive System Surgical Procedures - methods | Medical research | Analysis | Mortality | Colorectal cancer | Medicine, Experimental | Laparoscopic surgery | Health aspects | Health risk assessment
Locally advanced rectal cancer | Rectal cancer | Gynecology | Propensity score matching | Laparoscopy | Open surgery | Medicine & Public Health | Surgery | Hepatology | Gastroenterology | Radiochemotherapy | Abdominal Surgery | Proctology | SURGERY | RANDOMIZED CLINICAL-TRIAL | PATHOLOGICAL OUTCOMES | TOTAL MESORECTAL EXCISION | CIRCUMFERENTIAL MARGIN | LOCAL RECURRENCE | LOW ANTERIOR RESECTION | COLORECTAL-CANCER | PREOPERATIVE RADIOTHERAPY | NEOADJUVANT CHEMORADIOTHERAPY | ASSISTED RESECTION | Length of Stay | Adenocarcinoma - pathology | Rectal Neoplasms - surgery | Humans | Middle Aged | Proportional Hazards Models | Male | Survival Rate | Treatment Outcome | Propensity Score | Aged, 80 and over | Adult | Female | Aged | Rectal Neoplasms - pathology | Rectum - surgery | Laparotomy | Neoplasm Staging | Elective Surgical Procedures | Adenocarcinoma - surgery | Digestive System Surgical Procedures - methods | Medical research | Analysis | Mortality | Colorectal cancer | Medicine, Experimental | Laparoscopic surgery | Health aspects | Health risk assessment
Journal Article
Annals of Surgery, ISSN 0003-4932, 09/2011, Volume 254, Issue 3, pp. 486 - 493
Objective: To identify a biomarker profile associated with tumor response to chemoradiation (CRT) in locally advanced rectal cancer. Background: Rectal cancer...
SURGERY | K-RAS | CYCLIN D1 | MESORECTAL EXCISION | GENE-EXPRESSION | PREOPERATIVE CHEMORADIOTHERAPY | NONOPERATIVE TREATMENT | TUMOR-RESPONSE | PREDICTS RESPONSE | THYMIDYLATE-SYNTHASE | ADVANCED COLORECTAL-CANCER | Leucovorin - administration & dosage | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | United States | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Rectal Neoplasms - genetics | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Reproducibility of Results | Neoplasm Invasiveness | Rectal Neoplasms - surgery | Genotype | Proto-Oncogene Proteins - genetics | Treatment Outcome | Genes, p53 - genetics | Adenocarcinoma - drug therapy | Rectal Neoplasms - radiotherapy | Polymorphism, Genetic | Drug Resistance, Neoplasm - genetics | Cyclin D1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Aged | Biomarkers, Tumor - genetics | Mutation | Neoplasm Staging | Adenocarcinoma - surgery
SURGERY | K-RAS | CYCLIN D1 | MESORECTAL EXCISION | GENE-EXPRESSION | PREOPERATIVE CHEMORADIOTHERAPY | NONOPERATIVE TREATMENT | TUMOR-RESPONSE | PREDICTS RESPONSE | THYMIDYLATE-SYNTHASE | ADVANCED COLORECTAL-CANCER | Leucovorin - administration & dosage | Predictive Value of Tests | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | United States | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Rectal Neoplasms - genetics | Methylenetetrahydrofolate Reductase (NADPH2) - genetics | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Adenocarcinoma - genetics | Rectal Neoplasms - pathology | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Rectal Neoplasms - drug therapy | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Reproducibility of Results | Neoplasm Invasiveness | Rectal Neoplasms - surgery | Genotype | Proto-Oncogene Proteins - genetics | Treatment Outcome | Genes, p53 - genetics | Adenocarcinoma - drug therapy | Rectal Neoplasms - radiotherapy | Polymorphism, Genetic | Drug Resistance, Neoplasm - genetics | Cyclin D1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - methods | Aged | Biomarkers, Tumor - genetics | Mutation | Neoplasm Staging | Adenocarcinoma - surgery
Journal Article
Seminars in Colon and Rectal Surgery, ISSN 1043-1489, 06/2019, Volume 30, Issue 2, pp. 58 - 62
Management of rectal cancer has evolved extensively over the last 30 years. Treatment of locally advanced rectal cancer currently incorporates surgery,...
Neoadjuvant therapy | Locally advanced rectal cancer | Radiation
Neoadjuvant therapy | Locally advanced rectal cancer | Radiation
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 04/2019, Volume 46, Issue 4, pp. 878 - 888
PurposePathological complete response (pCR) following neoadjuvant chemoradiotherapy or radiotherapy in locally advanced rectal cancer (LARC) is reached in...
CT imaging | Locally advanced rectal cancer | STATISTICS | PERFORMANCE | PATHOLOGICAL RESPONSE | CHEMORADIOTHERAPY | CT TEXTURE ANALYSIS | PARAMETERS | TUMOR HETEROGENEITY | Radiomics | BIOMARKERS | F-18-FDG PET | Magnetic resonance imaging | Texture features | ASSOCIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prediction of treatment response
CT imaging | Locally advanced rectal cancer | STATISTICS | PERFORMANCE | PATHOLOGICAL RESPONSE | CHEMORADIOTHERAPY | CT TEXTURE ANALYSIS | PARAMETERS | TUMOR HETEROGENEITY | Radiomics | BIOMARKERS | F-18-FDG PET | Magnetic resonance imaging | Texture features | ASSOCIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prediction of treatment response
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2016, Volume 108, pp. 23 - 32
Highlights • A multidisciplinary team is essential in the management of localized rectal cancer. • Pre-operative chemoradiotherapy is the standard for...
Hematology, Oncology and Palliative Medicine | Neo-adjuvant | Chemo-radiotherapy | Rectal cancer | Surgery | Locally advanced | RANDOMIZED-TRIAL | WILD-TYPE KRAS | TOTAL MESORECTAL EXCISION | PATHOLOGICAL COMPLETE RESPONSE | RADIATION-THERAPY | PHASE-III TRIAL | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | NEOADJUVANT CHEMORADIOTHERAPY | POSTOPERATIVE ADJUVANT CHEMOTHERAPY | SHORT-COURSE RADIOTHERAPY | HEMATOLOGY | Rectal Neoplasms - diagnosis | Digestive System Surgical Procedures | Humans | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Neoplasm Staging | Rectal Neoplasms - therapy | Colorectal cancer
Hematology, Oncology and Palliative Medicine | Neo-adjuvant | Chemo-radiotherapy | Rectal cancer | Surgery | Locally advanced | RANDOMIZED-TRIAL | WILD-TYPE KRAS | TOTAL MESORECTAL EXCISION | PATHOLOGICAL COMPLETE RESPONSE | RADIATION-THERAPY | PHASE-III TRIAL | ONCOLOGY | PREOPERATIVE RADIOTHERAPY | NEOADJUVANT CHEMORADIOTHERAPY | POSTOPERATIVE ADJUVANT CHEMOTHERAPY | SHORT-COURSE RADIOTHERAPY | HEMATOLOGY | Rectal Neoplasms - diagnosis | Digestive System Surgical Procedures | Humans | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Neoplasm Staging | Rectal Neoplasms - therapy | Colorectal cancer
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 8/2019, Volume 23, Issue 8, pp. 1614 - 1622
Controversy exists over the use of adjuvant chemotherapy for locally advanced (stages II–III) rectal cancer (LARC) patients who demonstrate pathologic complete...
Pathologic complete responders | NCCN guidelines | Locally advanced rectal cancer | Medicine & Public Health | Surgery | Chemoradiation | Gastroenterology | Adjuvant therapy | SURGERY | LEUCOVORIN | METAANALYSIS | RANDOMIZED-TRIALS | OXALIPLATIN | FLUOROURACIL | POSTOPERATIVE CHEMOTHERAPY | NEOADJUVANT CHEMORADIOTHERAPY | PREOPERATIVE CHEMO RADIOTHERAPY | GASTROENTEROLOGY & HEPATOLOGY | Comorbidity | Analysis | Colorectal cancer | Adjuvant treatment | Cancer
Pathologic complete responders | NCCN guidelines | Locally advanced rectal cancer | Medicine & Public Health | Surgery | Chemoradiation | Gastroenterology | Adjuvant therapy | SURGERY | LEUCOVORIN | METAANALYSIS | RANDOMIZED-TRIALS | OXALIPLATIN | FLUOROURACIL | POSTOPERATIVE CHEMOTHERAPY | NEOADJUVANT CHEMORADIOTHERAPY | PREOPERATIVE CHEMO RADIOTHERAPY | GASTROENTEROLOGY & HEPATOLOGY | Comorbidity | Analysis | Colorectal cancer | Adjuvant treatment | Cancer
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 04/2019, Volume 120, Issue 4, pp. 5207 - 5217
Radiotherapy plays a crucial role in combined treatment modality in local advanced rectal cancer (LARC). While neoadjuvant chemoradiotherapy responses were...
long noncoding RNA | radiotherapy | microarray | local advanced rectal cancer | The Cancer Genome Atlas | ADJUVANT CHEMOTHERAPY | CELLS | LUNG | MECHANISM | STATISTICS | BIOCHEMISTRY & MOLECULAR BIOLOGY | COLON | CELL BIOLOGY | CETUXIMAB | INHIBITION | GENE-EXPRESSION | KRAS | Antisense RNA | Messenger RNA | Colorectal cancer | Genes | MiRNA | mRNA | Genomes | Radiation therapy | Gene expression | Patients | Computer programs | Medical prognosis | Rectum | Biomarkers | Combined treatment | Cancer
long noncoding RNA | radiotherapy | microarray | local advanced rectal cancer | The Cancer Genome Atlas | ADJUVANT CHEMOTHERAPY | CELLS | LUNG | MECHANISM | STATISTICS | BIOCHEMISTRY & MOLECULAR BIOLOGY | COLON | CELL BIOLOGY | CETUXIMAB | INHIBITION | GENE-EXPRESSION | KRAS | Antisense RNA | Messenger RNA | Colorectal cancer | Genes | MiRNA | mRNA | Genomes | Radiation therapy | Gene expression | Patients | Computer programs | Medical prognosis | Rectum | Biomarkers | Combined treatment | Cancer
Journal Article